Issue
In This Issue >>

"If We Don't Do It Then Who?"

Oladosu Ojengbede, director of the Center for Population and Reproductive Health at Nigeria’s University of Ibadan, attended a strategic leadership training course in 2002 sponsored by the Bill and Melinda Gates Institute for Population and Reproductive Health. Inspired by the course, Ojengbede decided to reduce one of the main causes of maternal death in Nigeria, eclampsia—seizures caused by severe hypertension during pregnancy. The condition can be effectively treated with magnesium sulfate, but in Nigeria the drug is expensive and difficult to obtain. He decided to manufacture it in Nigeria for one-fifth the cost. After a successful trial, Ojengbede is now securing grants to manufacture the drug and distribute it nationwide.
PREVIOUS 6 of 8 NEXT

Oladosu Ojengbede, director of the Center for Population and Reproductive Health at Nigeria’s University of Ibadan, attended a strategic leadership training course in 2002 sponsored by the Bill and Melinda Gates Institute for Population and Reproductive Health. Inspired by the course, Ojengbede decided to reduce one of the main causes of maternal death in Nigeria, eclampsia—seizures caused by severe hypertension during pregnancy. The condition can be effectively treated with magnesium sulfate, but in Nigeria the drug is expensive and difficult to obtain. He decided to manufacture it in Nigeria for one-fifth the cost. After a successful trial, Ojengbede is now securing grants to manufacture the drug and distribute it nationwide.

Support JHSPH

The Johns Hopkins Bloomberg School of Public Health strives every day to keep millions of people around the world safe from injury or illness.

Make a Gift

Search